RGRajiv Garg

Rajiv Garg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rajiv Garg has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Oxidative stress, antioxidant depletion, and DNA damage in post-COVID-19 patients: evidence of a disrupted redox network and loss of age-dependent antioxidant compensation

    by Nandini Dikshit, Surya Kant Tripathi, Jyoti Bajpai, Ajay Verma, Kausar Mahmood Ansari, Chamanpreet Kaur, Ishrat Jahan, Sanjeev Kumar Verma, Santosh Kumar, R. A. S. Kushwaha, et al.

    The relationship between oxidative stress and viral infections is well established, yet data on the redox consequences of COVID-19 beyond the acute phase remain sparse. We conducted a comprehensive assessment of oxidative stress biomarkers, antioxidant defences, and DNA damage in post-COVID patients, and examined whether COVID-19 infection disrupts the normal architecture of the antioxidant network. In this single-centre, cross-sectional, case–control study, 40 symptomatic post-COVID patients and 40 age- and sex-matched healthy controls were recruited from the Department of Respiratory Medicine, King George’s Medical University, Lucknow, India. Blood levels of lipid peroxidation (LPO), total antioxidant activity (TAA), superoxide dismutase (SOD), and glutathione reductase (GR) were measured. DNA damage was quantified using the alkaline comet assay. Data were analysed using Mann–Whitney U tests and Spearman rank correlations. Post-COVID patients showed profound antioxidant depletion: TAA was reduced by 60.8% (median 51.7 vs 224.3 mM; p < 0.001; Cohen’s d = 1.57), SOD by 34.0% (p < 0.001; d = 0.58), and GR by 35.0% (p < 0.001; d = 0.65). LPO was elevated but did not reach significance after correction for non-normality (p = 0.254), though it correlated significantly with radiographic severity (ρ = 0.403; p = 0.010) and was markedly elevated in patients with neurological involvement (2486.6 nmole/ml; p = 0.008). DNA damage was significantly increased across all comet parameters (% Tail DNA: + 24.0%; p < 0.001; d = 0.82). A novel finding was that the physiological age-dependent increase in TAA observed in controls (ρ = 0.425; p = 0.006) was abolished in patients (ρ = − 0.061; p = 0.707). Inter-marker correlation analysis revealed a rewiring of the antioxidant network, with breakdown of the normal LPO–TAA feedback relationship and emergence of SOD–TAA co-depletion. Post-COVID patients exhibit severe antioxidant depletion, significant DNA damage, and disruption of the normal redox network architecture. These findings provide a biochemical rationale for antioxidant-targeted therapeutic strategies in post-COVID management.

  • Open Access

    Incidence of nosocomial pneumonia and clinical outcomes of patients requiring non-invasive ventilation: A systematic review and meta-analysis

    by S Singhal, S K Mudgal, M Verma, M Gurjar, R Garg, R K Garg, B P Singh, J Singh

    Background. Non-invasive ventilation (NIV) is used for an increasing range of clinical conditions at various levels of care, including intensive care units (ICUs), and has been shown to carry a lower risk of nosocomial pneumonia (NP) compared with invasive mechanical ventilation (IMV). Objectives. To assess the incidence of NP and clinical outcomes (intubation rates and mortality) in patients receiving NIV as initial support. Methods. A systematic search of PubMed, Embase and Scopus for relevant research articles published in English was conducted up to 6 February 2025. Eligible studies included adult patients who received NIV for any respiratory condition and reported the incidence of NP. NP was defined as any new-onset pneumonia occurring at any point during the clinical course and ≥48 hours after initiating NIV. Furthermore, a subset of patients in whom NP was attributed solely to NIV support was defined as NIV-associated pneumonia (NIVAP). Two reviewers independently conducted database searches, data extraction and risk-of-bias assessment. A subgroup analysis was performed based on the indication for NIV, country and study design to identify heterogeneity. Results. We incorporated 30 studies, including 36 049 patients receiving NIV. Of these, 29 studies reported the incidence of NP, while only 22 reported the incidence of NIVAP. Overall, the incidence of NP was 6% (95% confidence interval (CI) 4 - 8; I2=89.4%), and the pooled incidence of NIVAP was 3% (95% CI 2 - 4; I2=32.9%). The rate of intubation was 28% (95% CI 22 - 35; I2=89.3%), and overall mortality was 18% (95% CI 15 - 23; I2=99.0%) among patients receiving NIV. Conclusion. NP, including NIVAP, remains a significant complication in patients receiving NIV. Our findings underscore the need for standardised diagnostic criteria for NP in patients receiving NIV.

  • Methylation based predictive biomarkers panel of genes for early detection and chemotherapy response in NSCLC

    by Supriya Karpathak, Rajiv Garg, Mohammad Kaleem Ahmad, Anand Srivastava, Anurag Kumar Srivastav, Neeraj Tiwari

  • Open Access

    Tuberculosis Following In Vitro Fertilization: A Systematic Review of Case Reports, Case Series, and Cohort Studies

    by Ravindra Kumar Garg, Hardeep Singh Malhotra, Vinay Suresh, Rajiv Garg, Amita Jain, Sarika Gupta, Smriti Agrawal

    Introduction: Tuberculosis (TB) remains a leading global health threat, with increasing concerns regarding post-in vitro fertilization (IVF) TB, especially in high-burden areas. Post-IVF maternal TB poses serious risks to both pregnant women and fetuses, often leading to miscarriage, fetal malformation, or mortality. Congenital TB, though rare, can result from maternal infection, with potentially devastating outcomes. Methods: A systematic review of case reports, case series, and cohort studies was conducted following PRISMA guidelines. Databases including PubMed, Scopus, Embase, and Google Scholar were searched until October 7, 2024, for studies related to TB following in vitro fertilization. Cases were evaluated for clinical presentations, diagnostics, treatment, and outcomes. We separately reviewed 11 cohort studies due to the lack of available individual patient data and the considerable variability in their methodologies. Results: Thirty-seven reports comprising 48 cases were analyzed, with the majority from Asia. Post-IVF TB is commonly presented as miliary TB in mothers, with systemic involvement including pulmonary, central nervous system (CNS), and genitourinary manifestations. Newborns frequently develop congenital TB, presenting with respiratory distress and neurological issues. The diagnosis was confirmed through techniques such as sputum polymerase chain reaction (PCR), endometrial biopsies, and imaging. Maternal outcomes improved with anti-TB therapy, while neonatal outcomes varied, with high mortality rates. Conclusion: Post-IVF TB manifests in mothers as miliary TB with systemic involvement; congenital TB in newborns often leads to respiratory distress, neurological complications, and high mortality. TB screening before IVF is critical in high-risk regions to prevent severe maternal and neonatal complications.


  • Open Access

    Linezolid induced lactic acidosis in tuberculosis: a systematic review of published case reports, case series

    by Rajiv Garg, Ravindra Kumar Garg, Pragati Garg, Anand Srivastava, Darshan Kumar Bajaj, Sandeep Bhattacharya

    Background: Linezolid is widely used in the treatment of drug-resistant tuberculosis (TB), but it is associated with severe adverse effects, including lactic acidosis, which remains underreported in the literature and is fatal in many cases. Methods: This systematic review followed PRISMA guidelines and was registered in PROSPERO (CRD42024552225). We conducted comprehensive searches across PubMed, Scopus, Embase, and Google Scholar, covering case reports and case series without language restrictions. Data were extracted on demographics, clinical presentation, Linezolid dosage, laboratory findings, treatment regimens, and outcomes. Lactic acidosis was defined as a serum pH 4 mmol/L. Quality assessment followed the protocol of Murad MH et al. Data were synthesized narratively and statistically analyzed using Microsoft Excel. Results: Seven case reports were identified. The average patient age was 49.33 years (range: 20–81 years), with a near-equal distribution between males and females. Most cases were reported from India (3/7). Respiratory symptoms predominated, with gastrointestinal and central nervous system involvement also noted. Linezolid dosing varied between 600 mg and 1200 mg daily. Arterial blood gas analysis showed significant acidosis, with pH values ranging from 6.09 to 7.32. Lactate levels were elevated (range: 10.2–20 mmol/L). Symptoms emerged within 7 days to over 1 month after starting Linezolid, except for one patient who developed symptoms immediately. Four patients died, and three survived after treatment modification. Conclusion: Linezolid-induced lactic acidosis is a rare but serious complication in drug-resistant TB, emphasizing the need for close monitoring and individualized treatment.


  • Assessment of Circulating Cell Free DNA Methylation Biomarker of Panel of Selected Genes for Lung Cancer Detection

    by Supriya Karpathak, Rajiv Garg, Mohammad Kaleem Ahmad, Anand Srivastava, Tabish Qidwai, Saba Ubaid, Anurag Kumar Srivastav

    Lung cancer (LC) is a well-known cause of cancer-related death worldwide. Early diagnosis of LC is an unmet need to improve the treatment response. In present study, we have analyzed the promoter methylation of a panel of genes in LC tissue and established tissue mirror biomarkers in plasma-derived circulating cell-free DNA (cfDNA). The mRNA expression of panel of genes (CDH1, CHFR, SOX10, and CAV1) were analyzed in tumor tissue (TT) including Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC) as compared to tumor-free tissue (TF) and correlated with gene promoter methylation in tissue-derived gDNA using methylation-specific PCR. The methylation analysis of genes were further analyzed in plasma-derived cfDNA of NSCLC and SCLC compared to healthy control. The methylation frequencies of CDH1, CHFR, and SOX10 were significantly higher (p < 0.05 to p < 0.001) in TT (59.45, 45.94 and 72.97%) compared to TF (21.42, 14.28 to 28.57%) respectively. Gene expressions in TT were down-regulated (p < 0.01) in contrast to TF and negatively correlated (p < 0.001) with hypermethylation, except CAV1, which showed up-regulation with hypomethylation in TT of NSCLC. The methylation status in cfDNA exploits similar results as tissue sample, exhibited significant hypermethylation (p ≤ 0.05 to p ≤ 0.001) in cfDNA of LC as compared to healthy control, and showed 58.33 to 76.47% positive predictive value and 51.47 to 66.33% negative predictive value. This study illustrated that gene promoter methylation analysis of the panel of genes in plasma samples has the potential for diagnosis of LC, and can be used as a tissue mirror biomarker.


  • Open Access

    A cross-sectional study to determine the psychological distress among pulmonary tuberculosis patients during COVID-19 pandemic

    by Ankita Mandal, Ajay Kumar Verma, Sanjeev Kumar Verma, Sujit Kumar Kar, Jyoti Bajpai, Surya Kant, Santosh Kumar, Ram Avadh Singh Kushwaha, Rajiv Garg, Anand Srivastava, et al.

    COVID-19 pandemic had adversely affected the services of the National Tuberculosis (TB) Elimination Programme, resulting in psychological distress among pulmonary tuberculosis patients (PTB). This cross-sectional, hospital-based study included 361 PTB patients. Three pre-defined questionnaires were used for the analysis, a questionnaire to evaluate anxiety related to COVID-19, a patient health questionnaire (PHQ-9) for depression, and a fear of COVID-19 scale (FCV-19S) questionnaire. Among 361 PTB patients, 13% (n=47) had COVID-19 infection. Out of the total patients, 69% (n=250) were DR-TB (drug resistance-tuberculosis) cases. Proportion of anxiety, fear and depression due to COVID-19 was found in 49% (n=177), 23% (n=83), 67% (n=247) respectively. Delay in the initiation of anti-tubercular treatment was found in 58% (n=210) of the cases, among which the majority, i.e., 69% (n=172, p=0.011), were DR-TB. This pandemic has led to a sudden step-down of PTB. Trend analysis of the psychological distress showed a peak following the COVID-19 pandemic. Most DR-TB patients had delayed initiation of the anti-tubercular treatment during the pandemic. The preponderance of the younger age group was seen in the pulmonary tuberculosis patients, and a majority of them had DR-TB. Depression was the predominant psychological distress among the study subjects during the pandemic.


  • Open Access

    Spectrum of interstitial lung diseases and their association with pulmonary hypertension

    by Richa Tyagi, Surya Kant, Sanjeev Kumar Verma, Ram Awadh Singh Kushwaha, Santosh Kumar, Rajiv Garg, Ajay Kumar Verma, Anand Srivastava, Darshan Kumar Bajaj, Anupam Wakhlu, et al.

    Interstitial lung diseases (ILDs) are an intriguing group of pulmonary disorders, which still require the study of epidemiological, genetic, pathophysiological, clinical, and radiological parameters. Pulmonary hypertension (PH) is an underreported complication in interstitial lung diseases which is associated with worse outcome. In our study, we have reported the spectrum of ILDs and estimated the prevalence of pulmonary hypertension among these subjects at a tertiary care centre. A cross-sectional study was performed in which demographical, clinical, radiological, and histological data of subjects with ILD, attending the department of Respiratory Medicine in the University was collected from 1st September 2018 to 31st August 2019. Serological tests were done wherever indicated. Standard criteria along with multidisciplinary opinion were needed to arrive at the final diagnosis. All subjects were screened for pulmonary hypertension via 2-D echocardiography. Mean pulmonary artery pressure ≥20 mmHg was used to define PH. In the defined period, 239 subjects were enrolled (58% females, n=141; mean age 52.38±13.40 years). A tissue diagnosis was obtained in 34% cases. The most common ILD was hypersensitivity pneumonitis (32.2%), followed by autoimmune-ILD (31.4%), idiopathic pulmonary fibrosis (IPF) (15.9%) and sarcoidosis (12.6%), non-IPF idiopathic interstitial pneumonitis (2.1%) and rest 21 (5.9%) subjects were diagnosed as other types of ILD. Pulmonary hypertension was seen in 46.0% of subjects.